NAMS MENOPAUSE CERTIFICATION EXAM Question and Answer (2026/2027) | Real Tested Questions | A+ Verified

NAMS MENOPAUSE CERTIFICATION EXAM
Question and Answer (2026/2027) | Real
Tested Questions | A+ Verified
• Characteristic hormonal change in menopause transition . CORRECT ANSWER:
Declining estrogen


• Reproductive stage of a 49-year-old with irregular periods and vasomotor
symptoms . CORRECT ANSWER: Perimenopause


• Definition of postmenopause . CORRECT ANSWER: 12 consecutive months
without menstruation


• Laboratory finding supporting menopause diagnosis in a 52-year-old woman .
CORRECT ANSWER: Elevated FSH (>25 IU/L)


• Most effective treatment for moderate-to-severe hot flashes . CORRECT
ANSWER: Hormone therapy


• Hormone therapy regimen for postmenopausal woman with intact uterus .
CORRECT ANSWER: Estrogen plus progestogen


• Recommended treatment for hot flashes in breast cancer survivor . CORRECT
ANSWER: Paroxetine


• Contraindication for systemic hormone therapy . CORRECT ANSWER:
Unexplained vaginal bleeding

, • Non-hormonal medication effective for menopausal sleep disturbances .
CORRECT ANSWER: Gabapentin


• Primary risk factor for osteoporosis in postmenopausal women . CORRECT
ANSWER: Estrogen deficiency


• Diagnosis for a 60-year-old woman with a T-score of -2.8 on DEXA scan .
CORRECT ANSWER: Osteoporosis


• Gabapentin . CORRECT ANSWER: Improves sleep and reduces hot flashes in
menopausal women.


• T-score of -2.8 on DEXA scan . CORRECT ANSWER: Indicates osteoporosis.


• First-line medication for postmenopausal osteoporosis treatment . CORRECT
ANSWER: Bisphosphonates.


• Recommended daily calcium intake for women aged 51-70 years . CORRECT
ANSWER: 1200 mg.


• Medication that reduces fracture risk and breast cancer risk . CORRECT
ANSWER: Raloxifene.


• Cardiovascular risk factor that increases significantly after menopause .
CORRECT ANSWER: Coronary artery disease.